The Thailand Food and Drug Administration (Thai FDA) has granted emergency use authorization (EUA) to Novavax and Serum Institute of India for a protein-based Covid-19 vaccine, NVX-CoV2373. Created from the genetic sequence of the initial […]
Opus Genetics and National Resilience have signed a strategic manufacturing services agreement for developing and manufacturing the former’s adeno-associated viral (AAV) vector-based gene therapies for inherited retinal diseases (IRD). Under the partnership, Resilience will offer […]
SMi Group reports: Exclusive speaker interview released with Takeda Pharmaceutical Company Ltd ahead of the Highly Potent API Conference Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking […]
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks’ time on April 27th and 28th, 2022. With just three […]
SMi Group reports: 6th Annual Highly Potent API Conference will return in May 2022 SMi Group has been working the Highly Potent Active Pharmaceutical Ingredients industry for 6 years now which has enabled the perfect […]